InsiderStreet Equity Research

Produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation for any investor. Do not rely on it for any investment decision.

Last Close

$94.11

2026-10-16

Market Cap

$75.0B

Volume

5.8M

52-Wk High

$99.33

52-Wk Low

$74.55

Trailing PE

37.0

P/S

3.56

Gross Margin

60.4%

Net Margin

9.7%

ROE

631%

ROIC

30%

Piotroski

8/9

Altman Z

6.9

1-Yr Return

+21.3%

5-Yr Return

+50.3%

Operating globally, Colgate-Palmolive Company and its affiliated entities are engaged in the production and distribution of a diverse range of consumer goods. Its operations are structured into two primary divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care division encompasses a broad array of offerings, spanning oral hygiene (e.g., toothpastes, toothbrushes, mouthwashes), personal care (e.g., bar and liquid soaps, shower gels, shampoos, conditioners, deodorants, antiperspirants, skin health items), and home care solutions (e.g., dishwashing detergents, fabric conditioners, household cleaners). These products are distributed through various channels, including traditional and online retailers, wholesalers, and distributors, under well-known brand names such as Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly. Furthermore, this segment supplies specialized pharmaceutical products to dentists and other professionals in oral healthcare. Conversely, the Pet Nutrition segment focuses on providing specialized pet food. This includes everyday nutritional options marketed under the Hill's Science Diet brand, as well as therapeutic diets designed to assist in managing various health conditions in dogs and cats, sold under the Hill's Prescription Diet brand. Distribution for these pet nutrition items occurs via pet supply stores, veterinary clinics, and online retail platforms. Established in 1806, Colgate-Palmolive Company maintains its corporate headquarters in New York, New York.

SectorConsumer DefensiveIndustryHousehold & Personal ProductsExchangeNYSEMarket Cap$75.0BEmployees33,600 (SEC-filed)CEONoel R. WallaceIPO1973-05-02CountryUS

300 Park Avenue, New York City, NY 10022-7499 · Tel 212 310 2000 · colgatepalmolive.com

INSIDERSTREET SCORE61 / 100Street mean $103.17 (6 analysts, last qtr) — their number, not ours

INSIDER CONSENSUS SIGNALROUTINE SELLING — LOW SIGNAL$32M sold / 6 mo, zero open-market buys

1 Year vs S&P 500 · CL +21.3% · S&P 500 +15.9% · spread +5.4pp

7 Years vs S&P 500 · CL +50.3% · S&P 500 +189.9% · spread -139.5pp

Both charts indexed to 100 at the start of their window and drawn on a single shared scale, so the gap to the benchmark is the gap you see. Adjusted closes throughout.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

INSIDERSTREET
SCORE61of 100

Score Breakdown

Profitability	72/100
Growth	49/100
Momentum	58/100
Quality	64/100
Earnings Quality	62/100
Balance Sheet	46/100
Value	39/100
Risk (safety)	100/100
Overall	60.5/100

Each component is a diagnostic reading on its own 0-100 scale. The overall score is computed separately from the underlying financials and is not the average of the rows above — components are not equally weighted and three of them (Momentum, Value, Risk) are derived partly from price rather than from the business.

Peer Comparison — IS Score

Symbol	IS Score
EL	54
KVUE	62
KMB	53
CHD	69
PG	64
CLX	40
CL	61

IS Score Trend — quarterly

14 quarters, 23 Q1 to 26 Q2. Peak 75 in 24 Q2, latest 61 — -14 since. Fell in 1 of the last 4 quarters. Dashed line marks 40 on the 0-100 scale.

BUSINESS QUALITY61 / 100IS Score 60.5 / 100 · -14.5 from peak of 75

Fundamental factor model, quarterly. Measures how the business is doing - not where the price is going.

PRICE STRUCTUREBULLISHTechnical Score 84 / 100 · Power +67 · 19 of 22 indicator votes bullish

Vote share across trend, momentum, volume, volatility and pattern families. Describes where the price is, not where it is going.

Both readings sit above the midpoint — business quality at 61 and price structure at 84 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.

Trigger	Where it stands now	What it would mean
IS Score reaches 75 and holds two consecutive quarters	now 60.5	would move us up one band
IS Score stops falling - one quarter higher than the prior	last four: 64 → 57 → 60 → 61	the direction matters more than the level
Technical vote share back above 50%	now 100%	price structure no longer broken
Institutional holder count rises two quarters running	peak 2,032 → now 2,032	fewer institutions willing to hold is our clearest warning

We publish these so the view can be shown to be wrong. If none of them move and our reading does, we owe you an explanation.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.

Site Convergence Score3 of 4top 4% of 29,420 symbols

Sources Aligned— of 3independent disclosures

Congress (180d)1 buys2026-06-02

Insider Buys (180d)0none disclosed

ETF Funds (30d)1235 up / 990 downnet +245 funds

Institutions Added (13F)67managers opening or increasing

Congressional and insider figures are disclosed purchases in the trailing 180 days; ETF figures are COUNTS OF FUNDS whose holding changed in 30 days, not dollars. Coincidence of separate disclosures, not coordination. An absent source means nothing qualifying was disclosed in its window.

Institutions holding — 12 quarters

Peak 2,032 · latest 2,032 (+0 from peak).

Quarter	Holders	13F shares	Value	Reported own%
2026 Q2	2,032	675.9M	$58.1B	84.8%
2026 Q1	1,965	675.4M	$53.5B	84.8%
2025 Q4	1,899	672.3M	$49.9B	84.4%
2025 Q3	1,848	669.0M	$50.1B	84.0%
2025 Q2	1,922	677.3M	$57.7B	85.0%
2025 Q1	1,951	682.6M	$60.4B	85.7%
2024 Q4	1,939	679.5M	$58.6B	85.3%
2024 Q3	1,914	674.3M	$66.2B	84.7%
2024 Q2	1,826	670.7M	$60.4B	84.2%
2024 Q1	1,776	678.7M	$56.3B	85.2%
2023 Q4	1,747	668.3M	$50.3B	83.9%
2023 Q3	1,626	666.3M	$45.2B	83.7%

How to read ownership above 100%. A 13F reports the positions a manager has investment discretion over, and where two or more managers share discretion over the same block, each one reports it. Summed across filers, the total can therefore exceed the shares actually outstanding without anything being wrong. We publish the figure as filed rather than netting it down, and flag separately any quarter where the arithmetic is not merely high but impossible.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Insider	Role	Date	Type	Shares	Value	Post-Txn Owned
Norrington Lorrie M	director	2026-10-01	A-Award	300	$0.03M	43,310
Newman Brian	director	2026-10-01	A-Award	214	$0.02M	8,058
Bilbrey John P	director	2026-10-01	A-Award	271	$0.02M	40,725
Wallace Noel R.	director, Chairman, President & CEO	2026-09-16	A-Award	29,649	—	379,700
Wallace Noel R.	director, Chairman, President & CEO	2026-09-16	A-Award	205,197	$17.86M	205,197
Grant Shane	COO, Americas	2026-09-16	A-Award	7,355	—	79,503
Grant Shane	COO, Americas	2026-09-16	A-Award	50,902	$4.43M	50,902
Tsourapas Panagiotis	COO, CD, EMEA, APac, Skin	2026-09-16	A-Award	4,597	—	11,447

6-mo decomposition (Form 4)	Txns	Shares	Value	Signal weight
S — Open-market sales	6	347,111	$32.0M	Counted
M — Exercises (paired A/D)	2	165,191	$11.9M	None — mechanics
F — Tax withholding	23	47,314	$4.2M	None — compensation
P — Open-market purchases	0	0	$0	Counted — none occurred

Monthly Net Insider Flow (000 shares)

Net of acquisitions minus dispositions, all Form 4 types.

Signal Summary

SignalRoutine Selling — Low Signal

Open-Market Sells$32.0M6 txns / 6 mo

Open-Market Buys$0.0M0 txns / 6 mo

ClusterNone active3+ insiders / 21 days

Filed	Filer	Shares registered	Est. proceeds
2026-08-24	Tsourapas Panagiotis	10,000	$0.9M
2026-08-06	Cahill John T	4,170	$0.4M
2026-08-05	Wallace Noel R.	161,021	$14.9M
2026-08-04	Wallace Noel R.	161,021	$14.8M
Trailing 12 mo	11 filings	574,374	$54M

Filed	Form	Reporting person	% of class	Shares
2026-04-29	SCHEDULE 13G	Vanguard Capital Management	7.52%	60.4M sh
2026-03-26	SCHEDULE 13G/A	The Vanguard Group	—	exit/reporting change
2025-02-07	SCHEDULE 13G/A	The Vanguard Group	10.05%	82.2M sh

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Member	Chamber	Trade	Size band	Traded	Disclosed
Ro Khanna	House	SELL	$1,001 - $15,000	2026-09-11	2026-10-09
Kevin Hern	House	SELL	$1,001 - $15,000	2026-09-02	2026-09-28
Kevin Hern	House	SELL	$1,001 - $15,000	2026-09-02	2026-09-25
John Boozman	Senate	SELL	$1,001 - $15,000	2025-10-09	2025-11-15
Shelley Moore Capito	Senate	SELL	$1,001 - $15,000	2025-07-31	2025-08-04
Shelley Moore Capito	Senate	SELL	$1,001 - $15,000	2025-07-31	2025-08-04

House 12-Mo35 trades7 purchases

Senate 12-Mo1 trades0 purchases

CoverageSTOCK Act filings30-45 day disclosure lag

13F Filers (last complete Q)1,965

13F Shares675M84.8% of shares out

New / Closed202 / 105positions, QoQ

Increased / Reduced717 / 705positions, QoQ

Put/Call (13F)0.97option positions

Free Float93.9%748M sh

2.8 · Largest Reporting 13F Managers

Manager	Shares	Value
Sarasin & Partners Llp	1.8M	$153M
Assenagon Asset Management S.A.	1.6M	$134M
Ninety One Uk Ltd	1.4M	$121M
Pinestone Asset Management Inc.	1.4M	$117M
Confluence Investment Management L	1.2M	$99M
Fjarde Ap-Fonden /Fourth Swedish N	581,491	$50M

EDGAR 13F holdings as of 2026-09-30; filer values normalized to dollars.

2.9 · Top ETF & Fund Ownership

Fund	Weight	Position
VITSX	0.1%	$2.2B
VTSAX	0.1%	$2.2B
VTI	0.1%	$2.2B
VSMPX	0.1%	$2.2B
VFFSX	0.1%	$1.8B
VOO	0.1%	$1.8B

13F Filers Holding CL — quarterly

Institutional Put/Call — quarterly

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Daily short-sale volume as % of volume reported in FINRA's short-sale file — a flow measure, not short interest; dashed = 50-day average.

Latest Session61.5%2026-10-15

20-Day Avg59.3%50-day 52.1%

TrendRising20d vs 50d

By Market CenterQ: 61% · N: 69% · B: 19%latest session

Weekly Notional ($B)

Where CL Trades in the Dark

ATS Venue (4-wk)	Shares	Avg trade
Incr Intelligent Cross Llc	7.1M	69 sh
Ubsa Ubs Ats	6.0M	65 sh
Mstx Ms Trajectory Cross (Ats-1)	3.7M	69 sh
Ebxl Level Ats	3.7M	37 sh
Sgmt Sigma X2	2.8M	66 sh
Pure Purestream	2.4M	40 sh

Where a dollar of Colgate-Palmolive Company revenue goes. All values FY2025 filings, live.

Region	Revenue	Share
Oral, Personal and Home Care	$4.8B	61%
Pet Nutrition	$3.1B	39%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

CL (live moat model)Peer median: EL · KVUE · KMB · CHD · PG

Component scores from the live moat model. Peer median illustrative.

Moat score 60/100 — Narrow; primary source Cost Advantage.

3.8 · Employees (SEC filings)

Officer	Title
Noel R. Wallace	Chairman, Chief Executive Officer & President
Shane Grant	Chief Operating Officer of Americas
Stanley J. Sutula	Chief Financial Officer
Panagiotis Tsourapas	COO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health

Revenue ($B)

EPS ($) — GAAP diluted actual, street-basis estimate

Actual bars are GAAP diluted EPS from the filed income statement; the lighter forward bars are street-basis consensus. The two are different measures and are not comparable quarter to quarter.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Quarterly EPS — Actual vs. Consensus

Beats (>2%)6 of 6recent quarters

Avg Surprise+3.8%

Next Report2026-10-30

Income Quality2.13OCF ÷ net income

Beat Rate—%0 of 0 quarters

Current Streak0longest 0

Avg EPS Surprise—%median —%

Surprise Trend—last 4 vs prior 4

Period	EPS est.	EPS actual	EPS surprise	Rev est. ($M)	Rev actual ($M)	Rev surprise

Announcement dates to . Consensus as it stood at each report. Revenue surprise shown where both estimate and actual are filed. A beat record is history, not a forecast.

Profit Margins (%)

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Revenue by Segment — Stacked

Live segmentation data.

YoY Growth Heatmap — Income Lines

YoY growth	FY21	FY22	FY23	FY24	FY25
Revenue	+5.8%	+3.1%	+8.3%	+3.3%	+1.4%
Gross profit	+3.6%	-1.4%	+10.8%	+7.6%	+1.2%
Operating income	-0.6%	-7.7%	+15.2%	+6.1%	-0.8%
Net income	-19.6%	-17.6%	+28.9%	+25.6%	-26.2%

$B · FY ends	FY21	FY22	FY23	FY24	FY25
Revenue	17.4	18.0	19.5	20.1	20.4
Cost of revenue	7.1	7.8	8.2	8.0	8.1
Gross profit	10.3	10.2	11.3	12.1	12.3
R&D expense	0.3	0.3	0.3	0.4	0.0
SG&A expense	6.1	6.2	6.8	7.8	7.9
Operating income	3.9	3.6	4.1	4.4	4.3
EBITDA	3.8	3.4	4.2	4.9	4.0
D&A	0.6	0.5	0.6	0.6	0.6
Pretax income	3.1	2.7	3.4	4.0	3.1
Income tax	0.7	0.7	0.9	0.9	0.8
Net income	2.2	1.8	2.3	2.9	2.1
Diluted EPS ($)	2.55	2.13	2.77	3.51	2.63
Diluted shares (M)	848	839	829	822	811

Operating CF$4B

CapEx$1B

Free cash flow$4B

SBC$0B

Buybacks$1B

Net cash change$0B

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet — Full

$B	FY22	FY23	FY24	FY25
Cash & equivalents	0.8	1.0	1.1	1.3
ST investments	0.0	0.0	0.2	0.0
Receivables (net)	1.5	1.6	1.5	1.7
Total current assets	5.1	5.3	5.3	5.7
PP&E (net)	4.3	4.6	4.4	4.7
Goodwill + intangibles	5.3	5.3	5.0	4.7
Total assets	15.7	16.4	16.0	16.3
Accounts payable	1.6	1.7	1.8	0.0
Short-term debt	0.0	0.3	0.7	0.0
Deferred revenue	0.0	0.0	0.0	0.0
Total current liabilities	4.0	4.7	5.8	5.7
Long-term debt	8.7	8.2	7.3	8.0
Total liabilities	14.9	15.4	15.5	16.0
Shareholders' equity	0.8	1.0	0.5	0.4

Cash Flow Statement — Full

$B	FY22	FY23	FY24	FY25
Net income	2.0	2.5	3.0	2.1
D&A	0.5	0.6	0.6	0.6
Stock-based compensation	0.1	0.1	0.1	0.0
Working capital change	(0.7)	0.5	0.3	0.3
Operating cash flow	2.6	3.7	4.1	4.2
Capital expenditures	(0.7)	(0.7)	(0.6)	(0.6)
Investing cash flow	(1.6)	(0.7)	(0.5)	(0.8)
Buybacks	(1.3)	(1.1)	(1.7)	(1.2)
Dividends paid	(1.7)	(1.7)	(1.8)	(1.8)
Debt issuance / (repay)	1.6	(0.3)	(0.4)	(0.5)
Financing cash flow	(1.0)	(2.8)	(3.4)	(3.3)
Free cash flow	1.9	3.0	3.5	3.6

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet Structure ($B)

Cash Generation vs Capex ($B)

Left: what the balance sheet is made of — the gap between the assets bar and the liabilities bar is book equity. Right: whether the capex bar is covered by the operating-cash bar; where it is not, the difference was funded externally and free cash flow goes negative.

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
PROFITABILITY
ROE	320.4%	353.5%	455.4%	704.0%	1602.3%	631%
ROA	14.0%	11.6%	14.3%	17.8%	13.2%	12.1%
ROIC	39.6%	31.1%	34.9%	46.8%	47.5%	29.9%
Gross margin	59.1%	56.5%	57.8%	60.2%	60.1%	60.4%
Operating margin	22.3%	20.0%	21.2%	21.8%	21.3%	20.7%
Net margin	12.4%	9.9%	11.8%	14.4%	10.5%	9.7%
EBITDA margin	21.6%	18.8%	21.8%	24.1%	19.4%	18.2%
FCF margin	15.8%	10.4%	15.6%	17.6%	17.8%	—
VALUATION
P/E	30.27	34.29	27.32	25.26	29.84	37.0
P/B	107.64	152.65	103.17	344.40	1177.54	317.6
P/S	3.76	3.41	3.23	3.63	3.12	3.56
P/FCF	23.77	32.91	20.67	20.59	17.50	19.4
EV/EBITDA	19.00	20.76	16.92	16.71	17.82	21.2
EV/Revenue	4.16	3.88	3.65	3.99	3.45	3.9
Earnings yield	3.3%	2.9%	3.7%	4.0%	3.4%	2.72%
FCF yield	4.2%	3.0%	4.8%	4.9%	5.7%	5.14%

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
LEVERAGE & SOLVENCY
Current ratio	1.09	1.28	1.11	0.92	1.00	1.03
Quick ratio	0.67	0.76	0.71	0.58	0.64	0.67
Debt / equity	12.86	23.12	14.88	40.15	147.93	33.29
Debt / assets	52.1%	58.9%	55.3%	53.0%	48.9%	46.8%
Net debt / EBITDA	1.83	2.53	1.93	1.51	1.70	1.69
Interest coverage	18.64	18.39	15.50	17.35	12.37	—

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
EFFICIENCY
Asset turnover	1.13	1.17	1.21	1.24	1.26	1.25
Receivables turnover	13.60	12.83	12.59	12.94	12.75	10.7
DSO (days)	27	28	29	28	29	34
DPO (days)	74	71	73	81	41	93
Cash conversion cycle	40	46	46	38	78	37
GROWTH (YoY)
Revenue growth	5.8%	3.1%	8.3%	3.3%	1.4%	—
Net income growth	-19.6%	-17.6%	28.9%	25.7%	-26.3%	—
EPS growth	-18.4%	-16.5%	30.3%	26.0%	-24.6%	—
FCF growth	-16.7%	-32.6%	63.4%	16.6%	2.5%	—
PER SHARE ($)
EPS (diluted, TTM)	2.56	2.14	2.79	3.51	2.65	2.56
Book value / share	0.72	0.48	0.74	0.26	0.07	0.71
Revenue / share	20.62	21.53	23.58	24.44	25.33	26.42
FCF / share	3.26	2.23	3.68	4.31	4.52	4.84
Cash / share	0.98	0.93	1.17	1.53	1.60	1.72
SHAREHOLDER RETURN & SCORES
Buyback yield	2.0%	2.1%	1.8%	2.4%	0.6%	0.66%
Altman Z-Score	6.96	6.46	6.56	7.19	4.31	6.9
Piotroski F-Score	6	6	8	8	7	8/9
Beneish M-Score	-2.83	-2.58	-2.87	-2.90	-3.01	-3.14

Model	Score	Zone	Note
Piotroski F-Score	8 / 9	Strong
Altman Z-Score	6.9	Safe (>2.99)	Safe
Income quality	2.13	Cash-backed	OCF ÷ net income
Beneish M-Score	-3.14	Non-manipulator	vs −2.22 threshold

DuPont Decomposition (TTM)	Value
Tax burden	0.69
Interest burden	0.92
Operating margin	15.2%
Asset turnover	1.23×
Financial leverage	36.52×
= ROE	434%

Growth Quality (live)	Value
Revenue stability	0.97
Earnings stability	0.01
Earnings persistence	0.88
Revenue CAGR 3y	4.1%
EPS CAGR 3y	12.0%
FCF CAGR 3y	17.9%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Buyback Yield0.66%

Dividend Yield2.23%

Total Shareholder Return2.91%cash yield

SBC / Revenue0.5%dilution pressure

Company	Mkt cap	P/E	ROE	Net margin	Rev growth	Piotroski	1-yr ret
EL	$37.9B	205.0	5%	-3.2%	+5.1%	7/9	+8.4%
KVUE	$36.3B	21.7	16%	11.5%	+1.8%	8/9	+35.7%
KMB	$35.1B	18.0	129%	8.2%	-12.3%	7/9	-11.8%
CHD	$24.8B	33.5	17%	13.3%	+2.7%	8/9	+21.4%
PG	$370.0B	23.6	30%	14.1%	+3.3%	6/9	—
CLX	$10.5B	18.1	286%	8.4%	-5.4%	4/9	—
TGT	$70.1B	15.9	26%	7.1%	+2.0%	6/9	—
MDLZ	$81.6B	23.4	13%	16.5%	+6.9%	6/9	—

1-yr returns computed from adjusted price history; peers without a tracked series show —.

Hold

45 Analysts

Str Sell (0)Sell (2)Hold (25)Buy (18)Str Buy (0)

Mean Target (qtr)$103.176 targets

Target vs. Price+9.6%last-quarter mean

Next Report2026-10-30street $0.93

Consensus estimates	Revenue mean	High / Low	EPS mean	High / Low	# EPS est.
FY2026	$21.42B	$21.55B / $21.09B	$3.86	$4.01 / $3.82	11
FY2027	$22.09B	$22.42B / $21.72B	$4.08	$4.17 / $4.01	12
FY2028	$22.90B	$23.48B / $22.39B	$4.39	$4.70 / $3.61	6

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Street Price Target — Trajectory

Window	Avg Target	vs. Price	# Targets
Last Month	$100.50	+6.8%	2
Last Quarter	$103.17	+9.6%	6
Last Year	$94.77	+0.7%	30
All Time	$90.97	-3.3%	70

Rolling mean of published targets vs. last close $94.11. Aggregated from StreetInsider, Benzinga, Pulse 2.0.

Third-Party Composite Rating

B

DCF

4/5

ROE

5/5

ROA

5/5

Debt/Eq

1/5

P/E

1/5

P/B

1/5

Independent quant composite as of 2026-10-16; components scored 1–5 (5 best). Shown for contrast with the InsiderStreet Score — methodologies differ.

CL +21.3% vs S&P 500 +15.9% — spread +5.4pp

Sector — XLP +11.4%

Peer Set — indexed to 100

All series indexed to 100 at the start of the window, adjusted closes.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Candlesticks with SMA 20/50 overlay, Bollinger (20,2σ) band, volume, and Wilder RSI(14) — computed from live daily OHLCV.

Moving Average	Value	Distance	% Distance	Signal
SMA 20	$87.71	+6.40	+7.30%	Above
SMA 50	$89.16	+4.95	+5.55%	Above
SMA 200	$88.91	+5.20	+5.85%	Above
EMA 9	$90.60	+3.51	+3.87%	Above
EMA 21	$89.00	+5.11	+5.74%	Above
EMA 50	$89.00	+5.11	+5.74%	Above
EMA 200	$88.40	+5.71	+6.46%	Above

Series and readings from the nightly technical-indicator history — identical data to the site's ribbon chart. Supertrend segments colored by direction.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

TECHNICAL VERDICTBULLISHPower Score +6719 of 22 indicator votes bullish

Family Scores (site weights)

Trend 30%100

Momentum 25%82

Volume 20%69

Volatility 10%100

Patterns 15%62

This Week100% bullishof 11 price-based votes

4 Weeks Ago9%+91 pts since

12 Weeks Ago27%+73 pts since

ReadImprovingweek-over-week trajectory

Price vs SMA 20$87.71

Price vs SMA 50$89.16

Price vs SMA 200$88.91

EMA 9/21 Cross90.6/89.0

SMA 50/200Golden

ADX DirectionADX 26

Supertrend$88

Parabolic SAR$88

SMA Slope0.330

RSI73.1

Stochastic K/D88/90

StochRSI K/D99/99

Williams %R-11

CCI192

TSI vs Signal18.3

CMO46.2

ROC11.65%

OBV SignalAccum

Chaikin MF-0.040

MFI77

Force Index3M

Elder Ray Bull5.11

RSI (14)30 oversold · 70 overbought

Stochastic %Kvs %D 90

Money Flowvolume-weighted RSI

ADXtrend strength · <20 weak

Williams %Rinverted scale

Level	Value	Level	Value
Pivot / R1 / R2	$93.37 / $94.63 / $96.58	S1 / S2	$91.42 / $90.16
Bollinger (20,2)	$82.25 – $93.17	Squeeze	Off
52-wk range	$74.55 – $99.33	Off 52-wk high	-5.3%
ATR (14)	$1.68 (1.8%)	Historical vol	19.9%

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

+0.7%Jan40%

+0.5%Feb60%

+1.3%Mar71%

+1.5%Apr70%

+0.6%May55%

+0.5%Jun55%

+0.6%Jul60%

-0.2%Aug50%

-0.0%Sep45%

+0.1%Oct60%

+2.7%Nov80%

+0.8%Dec50%

Sample: 20 years — treat short histories as suggestive, not statistical.

Computed from live weekly prices	CL	S&P 500
Weekly volatility (σ, 1y)	2.97%	1.83%
Best / worst week (1y)	+11.0% / -5.1%	—
Max drawdown (5y, monthly)	-22.8%	—
1-week VaR (95%)	-4.2%	—
Beta (5y)	0.32	1.00

CL EQUITY WEATHER (LIVE)CLOUDY · +11

Trend+44

Momentum+71

Volume-47

Volatility-60

Breadth-22

MARKET REGIME (2026-10-16)NEUTRAL

VIX19.99Normal

Dow TheoryConfirmed Bearish

SPY / QQQ TSI7.2 / 4.7trend strength

Sector Strength46/100breadth average

Average sentiment of 288 stories, weekly buckets, −1 to +1.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Overall+10.6+20.3 vs industry

Trend+44.1+44.6 vs industry

Momentum+71.4+68.3 vs industry

Volume-46.6-60.8 vs industry

Reading	CL	Household & Personal Products n=397	Consumer Defensive n=3,080	All US symbols n=70,435
Overall	+10.6	-9.7	-15.7	-20.5
Trend	+44.1	-0.4	-19.0	-21.3
Momentum	+71.4	+3.1	-6.2	-15.8
Volume	-46.6	+14.2	-5.0	-3.8

Trend, momentum and volume are computed per company. Volatility and breadth are market-regime values shared by every symbol in the universe, so they are reported once under Market Regime rather than compared here - a company cannot differ from its sector on a constant.

Executive	Total comp	Structure
Noel Wallace Chairman, President and Chief E	$16.5M	63% equity+incentive
Shane Grant Chief Operating Officer, America	$11.9M	80% equity+incentive
Stanley J. Sutula III Chief Financial Office	$5.7M	58% equity+incentive
Panagiotis Tsourapas Chief Operating Officer	$4.1M	54% equity+incentive
Jennifer M. Daniels Chief Legal Officer and	$3.8M	53% equity+incentive

Pillar (live disclosure scores)	Score
Environmental	69
Social	69
Governance	68
Composite ESG	69

Composite ESG Trend

Filed	8-K contents	Items
2026-07-31	Earnings Release; Exhibits	2.02,9.01
2026-05-13	Shareholder Vote	5.07
2026-05-01	Earnings Release; Exit/Disposal Costs; Exhibits	2.02,2.05,9.01
2026-04-09	Officer/Director Change	5.02
2026-03-17	Other Events; Financial Statements and Exhibits	8.01,9.01
2026-03-12	Departure/Election of Directors; Appointment of Officers	5.02
2026-01-30	Results of Operations and Financial Condition; Financial Statements an	2.02,9.01
2025-11-10	Other Events; Financial Statements and Exhibits	8.01,9.01

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.

DISCLOSURES. This document is produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation tailored to any person. Data is sourced as of the dates shown and may no longer be current. InsiderStreet.ai is not a registered investment adviser or broker-dealer. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Do not make any investment decision based on this document. © 2026 InsiderStreet.ai — all rights reserved. Redistribution prohibited.

Data domain	Source	Coverage for this report
Price & volume	market_db.historical_prices	52 rows
Fundamentals	income_statements_annual	6 rows · 2020 to 2025
Reported vs consensus	fact/earnings_calendar	24 rows · 2020-10-30 to 2026-07-31
Analyst estimates	dim/forward_estimates	3 rows · 2026-12-31 to 2028-12-31
Institutional ownership (13F)	holdings_db.institutional_ownership_summary	119 rows · 1996 to 2026
Insider transactions (Form 4)	edgar/form4	12 rows · 2026-09-16 to 2026-10-01
Proposed sales (Form 144)	edgar/form144	1 record
Beneficial ownership (13D/G)	edgar/13dg	3 rows · 2025-02-07 to 2026-04-29
Short-sale volume (FINRA)	edgar/short_volume_daily	60 rows · 2026-07-23 to 2026-10-15
Dark pool (ATS, tier 1)	edgar/darkpool_weekly	12 rows · 2026-06-15 to 2026-08-31
ETF & fund holding	etf_holdings_changelog (30d)	1 record
Peer set	stock_peers_dynamic	8 rows
Industry medians	industry_medians	1 record
Congressional trades	congress_db (House + Senate)	1 record
ESG	fact/esg_disclosures	1 record

Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.

Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.

Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL)

Score Breakdown

Peer Comparison — IS Score

IS Score Trend — quarterly

Colgate-Palmolive Company (CL)

Institutions holding — 12 quarters

Colgate-Palmolive Company (CL)

Monthly Net Insider Flow (000 shares)

Signal Summary

Colgate-Palmolive Company (CL)

2.8 · Largest Reporting 13F Managers

2.9 · Top ETF & Fund Ownership

13F Filers Holding CL — quarterly

Institutional Put/Call — quarterly

Colgate-Palmolive Company (CL)

Where CL Trades in the Dark

Colgate-Palmolive Company (CL)

3.8 · Employees (SEC filings)

Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL)

Balance Sheet — Full

Cash Flow Statement — Full

Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL)

Street Price Target — Trajectory

Third-Party Composite Rating

Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL)

Family Scores (site weights)

Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL)